First human receives reverse-aging gene therapy in groundbreaking trial targeting glaucoma, using cellular reprogramming to ...
Cellular reprogramming is the hottest topic in longevity science, with tech titans like Sam Altman investing in it. It's now ...
Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness.
Promising mouse studies and billions of dollars in funding are stoking excitement. But we’ve been here before.
4don MSN
Sci-Fi Becomes Reality: In A Historic Medical Milestone, First Human Receives Reverse-Aging Drug
The experimental treatment, known as ER-100, is being tested in patients suffering from glaucoma and other forms of ...
Paper in Cloning and Stem Cells shows that animal eggs do not support specific reprogramming toward the normal human embryonic state. Investigators at Advanced Cell Technology (ACTC) have found that ...
NewLimit Series C raises $435M led by Founders Fund as Armstrong-backed startup moves epigenetic therapies toward human ...
In a groundbreaking study published in Nature, Australian scientists have resolved a long-standing problem in regenerative medicine. Led by Professor Ryan Lister from the Harry Perkins Institute of ...
The Hearty Soul on MSN
The world's first reverse aging drug was just injected into a human
The world's first reverse aging drug, ER-100, was injected into a human on June 9, 2026 The post The World’s First ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results